# pyrazinamide

NDC: 0054-0812
Generic name: pyrazinamide
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20240830

FDA application: ANDA081319

## Active ingredients

- PYRAZINAMIDE: 500 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0054-0812"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0054-0812
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=566db230-3d73-482f-b67d-defd0b2dc46c